Activity of RBx 7644 and RBx 8700, new investigational oxazolidinones, against Mycobacterium tuberculosis infected murine macrophages

International Journal of Antimicrobial Agents

Volumn 25, Issue 6, 2005, Pages 464-468

  Sood, Ruchi ^a   Rao, Madhvi ^a   Singhal, Smitha ^a   Rattan, Ashok ^a  

^a RANBAXY RESEARCH LABORATORIES   (India)

Author keywords

Murine macrophages; Mycobacterium tuberculosis; Oxazolidinone

Indexed keywords

ISONIAZID; LINEZOLID; OXAZOLIDINONE DERIVATIVE; RANBAXY; RANBEZOLID; RBX 8700; RIFAMPICIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; IN VITRO STUDY; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MULTIDRUG RESISTANCE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REDUCTION;

ACETAMIDES; ANIMALS; ANTITUBERCULAR AGENTS; CELL LINE; DRUG ANTAGONISM; FURANS; ISONIAZID; MACROPHAGES; MICE; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; MYCOBACTERIUM TUBERCULOSIS; OXAZOLES; OXAZOLIDINONES; RIFAMPIN;

EID: 19544382696     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.01.021     Document Type: Article

References (15)

1. T.M. Arain, A.E. Resconi, D.C. Singh, and C.K. Stover Reporter gene technology to assess activity of antimycobacterial agents in macrophages Antimicrob Agents Chemother 40 1996 1542 1544
2. M.H. Cynamon, S.P. Klemens, C.A. Sharpe, and S. Chase Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model Antimicrob Agents Chemother 43 1999 1189 1191
3. D.R. Ashtekar, R. Costa-Periera, T. Shrinivasan, R. Iyyer, N. Vishwanathan, and W. Rittel Oxazolidinone a new class of synthetic antituberculosis agent: in vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis Diagn Microbiol Infect Dis 14 1991 465 471
4. M.R. Barbachyn, D.K. Huchinson, and S.J. Brickner Identification of novel oxazolidinone (U-100480) with potent antimycobacterial activity J Med Chem 39 1996 680 685
5. National Committee for Clinical Laboratory Standards. Susceptibility testing of Mycobacteria, Nocardia, and other Aerobic Actinomycetes: Tentative Standard M24-T2 NCCLS, vol. 20, no. 26; 2000.
6. G.E. Zuranko, H. Yagi, and R.D. Schaadt In vitro activities of U-100592 andU-100766, novel oxazolidinone antibacterial agents Antimicrob Agents Chemother 40 1996 839 845
7. B. Phetsuksiri, A.R. Baulard, and A.M. Cooper Antimycobacterial activities of isoxyl and new derivatives through inhibition of mycolic acid synthesis Antimicrob Agents Chemother 43 1999 1042 1051
8. B.Y. Zhao, R. Pine, J. Domagala, and K. Drlica Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: effects of a C8 methoxyl group on survival in liquid media and in human macrophages Antimicrob Agents Chemother 43 1999 661 666
9. J. Luna-Herrera, V.M. Reddy, D. Daneluzzi, and P.R.J. Gangadharama Antituberculosis activity of clarithromycin Antimicrob Agents Chemother 39 1995 2692 2695
10. N. Venkataprasad, R.M. Jacobs, L.J. Johnson, G. Klopman, and J.J. Ellner Activity of new quinolones against intracellular Mycobacterium avium in human monocytes J Antimicrob Chemother 40 1997 841 845
11. L.B. Heifets, P.J. Lindholm-Levy, and R.D. Comstock Clarithromycin minimal inhibitory and bactericidal concentrations Am Rev Respir Dis 145 1992 856 858
12. N. Mor, and L. Heifets MIC and MBC of clarithromycin against Mycobacterium avium within human macrophages Antimicrob Agents Chemother 37 1993 111 114
13. C. Perronne, A. Gikas, C. Truffot-Pernot, J. Grosset, J.J. Pocidalo, and J.L. Vilde Activities of clarithromycin, sulfisoxazole and rifabutin against Mycobacterium avium complex multiplication within human macrophages Antimicrob Agents Chemother 34 1990 1508 1511
14. S.P. Klemens, M.S. DeStefano, and M.H. Cyanamon Activity of clarithromycin against Mycobacterium avium infection in beige mice Antimicrob Agents Chemother 36 1992 2413 2417
15. S.W. Dooley, W.R. Jarvis, W.J. Martone, and D.E. Snider Multidrug-resistant tuberculosis Ann Int Med 117 1992 257 259